Maxidex (Dexamethasone)

Dexamethasone penetrates ocular tissues and binds to glucocorticoid receptors inside cells. This binding changes gene expression, suppresses phospholipase A2, and lowers production of prostaglandins, leukotrienes, and cytokines, thereby decreasing inflammation and edema in the eye.

The dosing regimen for Maxidex is determined by the prescribing ophthalmologist based on the specific condition, severity, and patient response. Typical regimens may involve one to several drops per eye per day, but the exact schedule should be followed as instructed by the healthcare provider.

Safety data for dexamethasone ophthalmic solution in pregnancy and lactation are limited. It should only be used if the potential benefit outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare professional.

To order Maxidex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The main alternative to Maxidex is prednisolone acetate eye drops. Both are glucocorticoids, but dexamethasone is more potent on a weight‑for‑weight basis, often requiring fewer drops. However, the choice depends on the clinician’s assessment of efficacy, tolerability, and patient‑specific factors.

Store Maxidex at room temperature, below 25 °C, in the original container. Keep the bottle tightly closed, protect it from light, and avoid exposure to moisture. Do not freeze the solution, and discard any product that appears discolored or contains particles.

Maxidex is applied as eye drops. The patient should wash hands, tilt the head back, pull down the lower eyelid to create a small pocket, and place the prescribed number of drops into the conjunctival sac. Close the eye gently for a few seconds and avoid blinking excessively.

Serious risks include a rapid increase in intra‑ocular pressure that can lead to glaucoma, secondary ocular infections, cataract formation with prolonged use, and rare corneal ulceration or melting. Patients should be monitored regularly for these complications, especially during extended therapy.

Maxidex should be avoided in patients with known hypersensitivity to dexamethasone or any component of the formulation, active viral, bacterial or fungal eye infections, and in individuals with uncontrolled glaucoma unless closely supervised by an ophthalmologist.